在乳腺癌细胞系中研究联合治疗的多重向方法
Jéssica Brzoskowski Longaray1, Camila Kehl Dias2, Juliete Nathali Scholl2
1Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
European journal of pharmacology
|January 18, 2024
概括
针对葡萄糖吸收和纯能信号的结合疗法在乳腺癌治疗中显示出有前途. 这种多目标方法诱导癌细胞死亡和细胞循环停止,为抗击这种疾病提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌 (BC) 是全球诊断最多的癌症,瘤微环境 (TME) 显著影响治疗耐药性和进展.
- 关键的TME因子,如腺素 (免疫抑制剂) 和葡萄糖 (瘤能量来源) 作为治疗点.
- 抑制纯能路径和葡萄糖吸收可能提供一种新的策略来对抗BC.
研究的目的:
- 在BC细胞中评估Dapagliflozin (SGLT2抑制剂),Paclitaxel (BC化疗) 和CD39/CD73抑制剂 (ARL67156/APCP) 联合治疗的疗效.
- 评估这些联合疗法对细胞活力,细胞循环和亡/亡的影响.
- 调查纯能信号抑制在乳腺癌生存机制中的作用.
主要方法:
- 使用了人类BC细胞系 (MCF-7和MDA-MB-231).
- 与达帕格利弗洛辛,帕克利塔克塞尔和ARL67156/APCP同时治疗的细胞.
- 进行了细胞活力测定,细胞周期分析和附录素/PI染色,以评估细胞亡和亡.
主要成果:
- 联合治疗导致通过细胞亡/亡和诱导细胞循环停止显著的细胞死亡.
- 达帕格利弗洛辛主要诱导了早期的亡,而帕克利塔塞尔导致了晚期的亡/亡.
- 抑制纯能信号传递,与其他药物结合,降低了细胞活力,这表明在BC生存中发挥了作用.
结论:
- 针对葡萄糖代谢和纯能信号传导的疗法组合证明了乳腺癌的有希望的多重向方法.
- 这些联合治疗有效诱导癌细胞死亡和细胞循环停止.
- 需要进一步的研究来阐明这些联合治疗策略背后的复杂相互作用和机制.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K